G Gambaran Penggunaan Obat Antihipertensi Di RSUD Sultan Suriansyah Banjarmasin

Wanda Nisa Pratiwi; Melviani Melviani

doi:10.33859/jpcs.v4i1.259

Authors

Wanda Nisa Pratiwi a:1:{s:5:"en_US";s:21:"Sari Mulia University";}
Melviani Melviani Sari Mulia University

DOI:

https://doi.org/10.33859/jpcs.v4i1.259

Keywords:

Antihypertension, Description, Drug use

Abstract

Background: The 2018 Riskesdas results the prevalence rate of hypertension in residents > 18 years based on national measurements of 34.11%. South Kalimantan Province has the highest prevalence of 44.13% (Ministry of Health of the Republic of Indonesia, 2018).

Objective: The description uses antihypertensive drugs in South Kalimantan using samples from the Sultan Suriansyah General Hospital, Banjarmasin.

Methods: This research was quantitative with an observational method with a cross-sectional design, data were collected retrospectively. This research took the form of patient medical record data at Sultan Suriansyah Hospital from January 2021 - March 2021.

Results: There were 138 hypertensive patients were taking antihypertensive drugs including CCB (Calcium Channel Blockers) at 44.20%, Beta Blockers at 23.91%, Diuretics at 15.94%, ARB (Angiotensin Receptor Blockers) at 9.42% and ACEi (Angiotensin Converging Enzym Inhibitor) 6.52%.

Conclusion: Based on the results the highest use of antihypertensive drugs was the CCB (Calcium Channel Blockers) group at 44.20% and the lowest was the ACEi group (Angiotensin Converting Enzym Inhibitor) at 6,52%.

References

JNC 8. (2014). Treatment of Hypertension: JNC 8 and More. Research Center, 3120(February), 209– 472.

www.PharmacistsLetter.com%5Cnwww.PrescribersLetter.com%5Cnwww.PharmacyTechnic iansLetter.com

Kementerian Kesehatan Republik Indonesia. (2018). Laporan Nasional RISKESDAS 2018. In Kementrian Kesehatan RI. https://dinkes.kalbarprov.go.id/wp- content/uploads/2019/03/Laporan-Riskesdas-2018-Nasional.pdf

Kementerian Kesehatan RI. (2019). Peraturan Menteri Kesehatan Republik Indonesia Nomor 30 Tahun 2019 Tentang Klasifikasi Dan Perizinan Rumah Sakit. Peraturan Menteri Kesehatan, 8(5), 55.

Lisni, I., Nurisma Oktavia, Y., & Iskandar, D. (2020). Kajian Kerasionalan Peresepan Obat Antihipertensi Di Salah Satu Puskesmas Kota Bandung. Jurnal Ilmiah Farmako Bahari, 11(1), 1. https://doi.org/10.52434/jfb.v11i1.695

Pusat Data Dan Informasi Kementerian Kesehatan RI. (2019). HIPERTENSI. InfoDATIN.